ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag heart failure disease medicine ecology

Notebook
Paul Smaglik | Nov 21, 1999 | 6 min read
Contents Pivotal pump Leptin limbo Clue to obesity Biotech Web site Helping hand Mapping malaria UCSD - Salk Program in Molecular Medicine HEART FAILURE RESCUE: A cross section of a mouse genetically engineered to develop heart failure (left) shows enlarged heart chambers and thin walls that are typical of the condition. A cross section from the same strain of mouse, but with the phospholamban gene (PLB) also missing, appears normal. PIVOTAL PUMP A biochemical calcium pump and the gene that con
Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
Letters
The Scientist Staff | Aug 1, 2006 | 5 min read
Restoring natural capital As scientists and practitioners committed to ecological restoration, we found the analogy you made in your April issue1 between restoring natural capital (RNC)2 and new forms of cancer treatment3 to be an extremely powerful one. To a certain degree, RNC and ecological restoration in general, are indeed related to ecosystem degradation in the way that tumor ecology-based treatments are related to traditional cancer therapies, e.g., combined
Six-Legged Syringes
Yao-Hua Law | Sep 1, 2014 | 4 min read
Researchers whose work requires that they draw blood from wild animals are finding unlikely collaborators in biting insects.
New MRIs on the Horizon
A. J. S. Rayl | Mar 19, 2000 | 7 min read
Courtesy of National Heart, Lung, and Blood InstituteMRI scans of the heart: upper left, torso with heart; upper right, cross section at aortic valve; lower left, lateral view of heart, pulmonic valve, and descending aorta; lower right, four-chamber view In the not too distant future, emergency rooms may well take on the aura of Star Trek's hospital bay. New, state-of-the-art magnetic resonance imaging (MRI) machines offer fast, efficient, and highly detailed data, allowing physicians to make im
The Proteasome: A Powerful Target for Manipulating Protein Levels
John Hines and Craig M. Crews | May 1, 2017 | 10+ min read
The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.
The Little Cell That Could
Megan Scudellari | Jul 1, 2012 | 7 min read
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
Opinion: Coronavirus Pandemic Highlights Dangers of Health Disparities
Matthew Dacso, Kara McArthur, and Clifford Dacso | Jul 13, 2020 | 4 min read
The coronavirus pandemic is exposing the underlying biological dangers of being a minority in the US.
The Surgisphere Scandal: What Went Wrong?
Catherine Offord | Oct 1, 2020 | 10+ min read
The high-profile retractions of two COVID-19 studies stunned the scientific community earlier this year and prompted calls for reviews of how science is conducted, published, and acted upon. The warning signs had been there all along.
Biosense or Biononsense
Katherine Eban | Apr 1, 2007 | 10+ min read
Biosense or Biononsense? Years of development and hundreds of millions of dollars later, what has the CDC's syndromic surveillance program accomplished?By Katherine Eban ARTICLE EXTRAS Syndromic Surveillance in California It was two days before Thanksgiving 2004, when an epidemiologist in New Jersey's public health agency picked up a heart-stopping electronic message. The

Run a Search

ADVERTISEMENT